MBRX

Moleculin Biotech Inc Cross-source read$0.71 13.86%
Health CareCUSIP 60855D408· EOD Sep 11, 2026

Among active 13F managers last quarter, 2 added and none reduced or exited; the largest holder to move was Tower Research Capital LLC (TRC) (+32%). Over the last 180 days, 3 insiders bought and none sold, a net $0 in open-market trades.

Tracked 13F holders
14
4 in Q2 2026 filings
13F value (tracked)
$358K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
2 adding · 0 trimming
Insiders · Form 4 open-market, 180d
3 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$0.71 13.86%5Y -99.9%
$0.38$307.06$613.75$920.43$1,2272021202220232024202520264323423
Hover for who · click for detailEnd-of-day closing prices52w $0.39 – $13.25

Who owns MBRX?

14 tracked 13F filers · ranked by shares held

14 tracked 13F filers disclose a position in MBRX as of the latest SEC 13F filings, a combined $358K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Geode Capital Management, LLC47K
$132K
+46%
Added · +15K sh
Q2 2026
2Vanguard Capital Management LLC42K
$118K
+204%
Added · +28K sh
Q2 2026
3Vanguard Fiduciary Trust Co30K
$83K
+392%
Added · +24K sh
Q2 2026
4Rockefeller Capital Management L.P.4K
$10K
20×
Added · +4K sh
Q1 2026
5UBS Group AG3K
$8K
−42%
Reduced · −2K sh
Q1 2026
6Tower Research Capital LLC (TRC)2K
$4K
+32%
Added · +442 sh
Q1 2026
7BlackRock, Inc.491
$1K
Held
Q2 2026
8EFG International AG434
$1K
Held
Q2 2026
9NFSG Corp114
$318
Held
Q2 2026
10SBI Securities Co., Ltd.44
$123
+2.3%
Added · +1 sh
Q2 2026
11Morgan Stanley36
$83
Held
Q1 2026
12Danske Bank A/s2
$6
Held
Q2 2026
13CVA Family Office, LLC1
$3
Held
Q2 2026
14Osaic Holdings, Inc.1
$2
Held
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is MBRX being bought or sold by institutions?

Last quarter, 2 funds added to an existing position in MBRX, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Added
2
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own MBRX also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA5 funds$873.7M
Apple IncAAPL5 funds$472.4M
Microsoft CorpMSFT5 funds$401.9M
Amazon.com IncAMZN5 funds$350.5M
Invesco QQQ Trust Series 1QQQ5 funds$327.1M
Vanguard S&P 500 ETFVOO5 funds$316.5M
Alphabet Inc-CL AGOOGL5 funds$266.3M
Alphabet Inc-CL CGOOG5 funds$250.0M
Micron Technology IncMU5 funds$249.5M
Broadcom IncAVGO5 funds$239.3M
Tesla IncTSLA5 funds$218.1M
Applied Materials IncAMAT5 funds$195.8M

Ranked by how many of MBRX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in MBRX.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
3 insiders
Net · 180d
$0
3 open-market transactions
DateInsiderRoleActionSharesValue
Aug 3, 2026Foster Jonathan P.Chief Financial OfficerBuy (P)293K
Aug 3, 2026Klemp Walter VCEO and President, DirectorBuy (P)533K
Aug 3, 2026Picker Donald HChief Science OfficerBuy (P)173K
Jun 23, 2025Klemp Walter VCEO and President, DirectorBuy (P)676K$250K
Jun 23, 2025Foster Jonathan P.Chief Financial OfficerBuy (P)270K$100K
Dec 26, 2023Klemp Walter VCEO and President, DirectorBuy (P)188K$130K
Dec 26, 2023George Robert E.DirectorBuy (P)14K$10K
Dec 26, 2023Foster Jonathan P.Chief Financial OfficerBuy (P)29K$20K
Nov 25, 2022Klemp Walter VCEO and President, DirectorBuy (P)45K$58K
Nov 21, 2022Klemp Walter VCEO and President, DirectorBuy (P)23K$26K
Nov 17, 2022Klemp Walter VCEO and President, DirectorBuy (P)25K$25K
Nov 16, 2022Klemp Walter VCEO and President, DirectorBuy (P)85K$83K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
61
Insiders
Form 4 open-market
30$0
US House
STOCK Act trades
00$0
Sector rotation
MBRX is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

4 tracked filers in Q2 2026 filingsstill filing
0917Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $133K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for MBRX

Browse more

Build

Ask your agent what changed in MBRX

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/MBRX/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for MBRX.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MBRX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.